COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...
WebMD2y
COPD Resource Center
You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...
Verywell Health on MSN1y
Pulmonary Hygiene for Respiratory Disease
Deep breathing, lung exercises, and tapping on the chest are a few of the techniques that fall under what's known as ...
Armed robbery in Revesby8d
Broadened COPD, Metabolic Study Aims to Boost Care
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve ...
pharmaphorum1y
Sanofi, Regeneron flesh out COPD data with Dupixent
Sanofi and Regeneron have built their case for Dupixent as a first biological therapy for chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS) congress, as they ...
Verona Pharma’s Ohtuvayre: Unique COPD Solution Drives Buy Rating Amid Market Potential and Revenue Growth
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...